Survey of Cancer Patients' Perceptions of Difficulties Encountered When Filling Opioid Prescriptions
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03989128|
Recruitment Status : Recruiting
First Posted : June 18, 2019
Last Update Posted : July 8, 2019
|Condition or disease||Intervention/treatment|
|Malignant Neoplasm Pain||Other: Medical Chart Review Other: Survey Administration|
I. To evaluate patients' perceptions of overall difficulties when filling their opioid prescription.
I. To determine cancer patients' perceptions of financial, logistical, and psychosocial difficulties when filling their opioid prescription.
II. To evaluate the association between patient characteristics and patient difficulty filling opioid prescriptions.
Participants complete a survey over 5-10 minutes.
|Study Type :||Observational|
|Estimated Enrollment :||140 participants|
|Official Title:||A Survey to Determine Cancer Patients' Perceptions of the Difficulties Encountered When Filling Opioid Prescriptions|
|Actual Study Start Date :||April 23, 2019|
|Estimated Primary Completion Date :||January 1, 2021|
|Estimated Study Completion Date :||January 1, 2021|
Participants complete a survey over 5-10 minutes
Other: Medical Chart Review
Undergo medical chart review
Other Name: Chart Review
Other: Survey Administration
- Patients' perception of overall difficulties when filling opioid prescriptions [ Time Frame: 2 years ]The proportion of patients who have experienced any difficulty when filling their prescription will be reported along 95% confidence intervals. Association of patients' characteristics with experiencing difficulty will be evaluated by Wilcoxon rank sum test and chi-square (Fisher's exact) test for continuous and categorical variables, respectively.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03989128
|Contact: Eduardo Bruerafirstname.lastname@example.org|
|United States, Texas|
|M D Anderson Cancer Center||Recruiting|
|Houston, Texas, United States, 77030|
|Contact: Eduardo Bruera 713-792-6082|
|Principal Investigator: Eduardo Bruera|
|Principal Investigator:||Eduardo Bruera||M.D. Anderson Cancer Center|